C93.31 Juvenile myelomonocytic leukemia, in remission
Get what a quick lookup can't: the AI assistant for official-guideline questions, HCC risk-adjustment mappings (CMS-HCC V24/V28, RxHCC), FDA drug indications, and AHA Coding Clinic references for C93.31.
The ICD-10-CM code for Juvenile myelomonocytic leukemia, in remission is C93.31 (FY2026). It is a billable, claim-ready diagnosis code.
Classification
- Chapter
- 2: Neoplasms (C00-D49)
- Section
- C81-C96: Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
- Category C93
- 21 codes (15 billable)
- FY2026 Status
- Stable since FY2024
U.S. Hospital Utilization
C93.31 appeared in too few sampled U.S. inpatient stays in 2023 to report a national estimate (AHRQ suppresses counts of 10 or fewer) — a rare inpatient diagnosis.
Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.
Official Coding Guidelines
Tx of primary site (TOC entry)a. Admission/Encounter for treatment of primary site ............................................................. 33
Tx of secondary site (TOC entry)b. Admission/Encounter for treatment of secondary site .......................................................... 33
Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026
References
Cite This Page
Reference C93.31 with the canonical source and edition:
C93.31 — Juvenile myelomonocytic leukemia, in remission. ICD-10 Coding Pro (ICD-10-CM FY2026). https://icd10codingpro.com/codes/C93.31
Canonical URL: https://icd10codingpro.com/codes/C93.31